ARS Pharmaceuticals Inc.

NASDAQ: SPRY · Real-Time Price · USD
14.53
0.06 (0.41%)
At close: Aug 15, 2025, 3:59 PM
14.65
0.83%
After-hours: Aug 15, 2025, 07:32 PM EDT

ARS Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
127.87 -9.6 -9.83 -9.5
PEG Ratio
-1.12 0.28 -0.4 -0.00
PS Ratio
11.47 17.39K 258.99 34.92
PB Ratio
3.98 2.26 1.25 4.30
P/FCF Ratio
78.76 -8.78 -8.46 -10.92
P/OCF Ratio
75.49 -8.8 -8.5 -10.95
OCF/S Ratio
0.15 -1.98K -30.45 -3.19
Debt / Equity Ratio
0.00 0.00 0.00 0.20
Quick Ratio
14.04 96.92 51.01 7.42
Current Ratio
14.26 96.92 51.01 7.42
Asset Turnover
0.25 0.00 0.00 0.09
Interest Coverage
n/a n/a n/a -183.53
Return on Equity
0.03 -0.24 -0.13 -0.45
Return on Assets
0.02 -0.23 -0.12 -0.33
Return on Invested Capital
-0.01 -0.29 -0.13 -0.34
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.99 1.00 0.76 0.96
Net Profit Margin
0.09 -1.81K -26.35 -3.68
Pretax Profit Margin
0.09 -1.81K -26.35 -3.68
Operating Profit Margin
-0.03 -2.25K -26.99 -3.53
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.03 -2.25K -26.11 -3.49